Structure and Function of Inter-α-Trypsin Inhibitor Heavy Chains

REFERENCES

• Steinbuch M. The inter-alpha-trypsin inhibitor. Methods Enzymol. 1976; 45: 760–772
   PubMedGoogle Scholar
• Gebhard W., Hochstrasser K., Fritz H., Enghild J.J., Pizzo S.V., Salvesen G. Structure of inter-alpha-inhibitor (inter-alpha-trypsin inhibitor) and pre-alpha-inhibitor: current state and proposition of a new terminology. Biol. Chem. Hoppe Seyler 1990; 371(Suppl)13–22
   PubMed Web of Science ®Google Scholar
• Salier J.P. Inter-alpha-trypsin inhibitor: emergence of a family within the Kunitz-type protease inhibitor superfamily. Trends Biochem. Sci. 1990; 15: 435–439
   PubMed Web of Science ®Google Scholar
• Salier J.P., Rouet P., Raguenez G., Daveau M. The inter-alpha-inhibitor family: from structure to regulation. Biochem. J. 1996; 315(Pt 1)1–9
   PubMed Web of Science ®Google Scholar
• Zhuo L., Hascall V.C., Kimata K. Inter-alpha-trypsin inhibitor, a covalent protein-glycosaminoglycan-protein complex. J. Biol. Chem. 2004; 279: 38079–38082
   PubMed Web of Science ®Google Scholar
• Fries E., Blom A.M. Bikunin—not just a plasma proteinase inhibitor. Int. J. Biochem. Cell Biol. 2000; 32: 125–137
   PubMed Web of Science ®Google Scholar
• Kanayama N., Maehara K., She L., Belayet H.M., Khatun S., Tokunaga N., Terao T. Urinary trypsin inhibitor suppresses vascular smooth muscle contraction by inhibition of Ca2+ influx. Biochim. Biophys. Acta 1998; 1381: 139–146
   PubMed Web of Science ®Google Scholar
• Forteza R., Casalino-Matsuda S.M., Monzon M.E., Fries E., Rugg M.S., Milner C.M., Day A.J. TSG-6 potentiates the antitissue kallikrein activity of inter-alpha-inhibitor through bikunin release. Am. J. Respir. Cell Mol. Biol. 2007; 36: 20–31
   PubMed Web of Science ®Google Scholar
• Bost F., Diarra-Mehrpour M., Martin J.P. Inter-alpha-trypsin inhibitor proteoglycan family—a group of proteins binding and stabilizing the extracellular matrix. Eur. J. Biochem. 1998; 252: 339–346
   PubMedGoogle Scholar
• Fries E., Kaczmarczyk A. Inter-alpha-inhibitor, hyaluronan and inflammation. Acta Biochim. Pol. 2003; 50: 735–742
   PubMed Web of Science ®Google Scholar
• Laurent T.C. Biochemistry of hyaluronan. Acta Otolaryngol. Suppl. 1987; 442: 7–24
   PubMedGoogle Scholar
• Fraser J.R., Laurent T.C., Laurent U.B. Hyaluronan: its nature, distribution, functions and turnover. J. Intern. Med. 1997; 242: 27–33
   PubMed Web of Science ®Google Scholar
• Toole B.P. Hyaluronan: from extracellular glue to pericellular cue. Nat. Rev. Cancer 2004; 4: 528–539
   PubMed Web of Science ®Google Scholar
• Yoneda M., Suzuki S., Kimata K. Hyaluronic acid associated with the surfaces of cultured fibroblasts is linked to a serum-derived 85-kDa protein. J. Biol. Chem. 1990; 265: 5247–5257
   PubMed Web of Science ®Google Scholar
• Huang L., Yoneda M., Kimata K. A serum-derived hyaluronan-associated protein (SHAP) is the heavy chain of the inter alpha-trypsin inhibitor. J. Biol. Chem. 1993; 268: 26725–26730
   PubMed Web of Science ®Google Scholar
• Zhao M., Yoneda M., Ohashi Y., Kurono S., Iwata H., Ohnuki Y., Kimata K. Evidence for the covalent binding of SHAP, heavy chains of inter-alpha-trypsin inhibitor, to hyaluronan. J. Biol. Chem. 1995; 270: 26657–26663
   PubMed Web of Science ®Google Scholar
• Zhuo L., Yoneda M., Zhao M., Yingsung W., Yoshida N., Kitagawa Y., Kawamura K., Suzuki T., Kimata K. Defect in SHAP-hyaluronan complex causes severe female infertility. A study by inactivation of the bikunin gene in mice. J. Biol. Chem. 2001; 276: 7693–7696
   PubMed Web of Science ®Google Scholar
• Zhuo L., Kanamori A., Kannagi R., Itano N., Wu J., Hamaguchi M., Ishiguro N., Kimata K. SHAP potentiates the CD44-mediated leukocyte adhesion to the hyaluronan substratum. J. Biol. Chem. 2006; 281: 20303–20314
   PubMed Web of Science ®Google Scholar
• de la Motte C.A., Hascall V.C., Drazba J., Bandyopadhyay S.K., Strong S.A. Mononuclear leukocytes bind to specific hyaluronan structures on colon mucosal smooth muscle cells treated with polyinosinic acid:polycytidylic acid: inter-alpha-trypsin inhibitor is crucial to structure and function. Am. J. Pathol. 2003; 163: 121–133
   PubMed Web of Science ®Google Scholar
• Selbi W., de la Motte C.A., Hascall V.C., Day A.J., Bowen T., Phillips A.O. Characterization of hyaluronan cable structure and function in renal proximal tubular epithelial cells. Kidney Int. 2006; 70: 1287–1295
   PubMed Web of Science ®Google Scholar
• Chan P., Risler J.L., Raguenez G., Salier J.P. The three heavy-chain precursors for the inter-alpha-inhibitor family in mouse: new members of the multicopper oxidase protein group with differential transcription in liver and brain. Biochem. J. 1995; 306(Pt 2)505–512
   PubMed Web of Science ®Google Scholar
• Blom A.M., Morgelin M., Oyen M., Jarvet J., Fries E. Structural characterization of inter-alpha-inhibitor. Evidence for an extended shape. J. Biol. Chem. 1999; 274: 298–304
   PubMed Web of Science ®Google Scholar
• Castillo G.M., Templeton D.M. Subunit structure of bovine ESF (extracellular-matrix stabilizing factor(s)). A chondroitin sulfate proteoglycan with homology to human I alpha i (inter-alpha-trypsin inhibitors). FEBS Lett. 1993; 318: 292–296
   PubMed Web of Science ®Google Scholar
• Yamamoto T., Yamamoto K., Sinohara H. Inter-alpha-trypsin inhibitor and its related proteins in Syrian hamster urine and plasma. J. Biochem. (Tokyo) 1996; 120: 145–152
   PubMed Web of Science ®Google Scholar
• Thuveson M., Fries E. Intracellular proteolytic processing of the heavy chain of rat pre-alpha-inhibitor. The COOH-terminal propeptide is required for coupling to bikunin. J. Biol. Chem. 1999; 274: 6741–6746
   PubMed Web of Science ®Google Scholar
• Heron A., Bourguignon J., Calle A., Borghi H., Sesboue R., Diarra-Mehrpour M., Martin J.P. Post-translational processing of the inter-alpha-trypsin inhibitor in the human hepatoma HepG2 cell line. Biochem. J. 1994; 302(Pt 2)573–580
   PubMed Web of Science ®Google Scholar
• Thogersen I.B., Enghild J.J. Biosynthesis of bikunin proteins in the human carcinoma cell line HepG2 and in primary human hepatocytes. Polypeptide assembly by glycosaminoglycan. J. Biol. Chem. 1995; 270: 18700–18709
   PubMed Web of Science ®Google Scholar
• Thuveson M., Fries E. The low pH in trans-Golgi triggers autocatalytic cleavage of pre-alpha -inhibitor heavy chain precursor. J. Biol. Chem. 2000; 275: 30996–31000
   PubMed Web of Science ®Google Scholar
• Kaczmarczyk A., Thuveson M., Fries E. Intracellular coupling of the heavy chain of pre-alpha-inhibitor to chondroitin sulfate. J. Biol. Chem. 2002; 277: 13578–13582
   PubMed Web of Science ®Google Scholar
• Saguchi K., Tobe T., Hashimoto K., Sano Y., Nakano Y., Miura N.H., Tomita M. Cloning and characterization of cDNA for inter-alpha-trypsin inhibitor family heavy chain-related protein (IHRP), a novel human plasma glycoprotein. J. Biochem. (Tokyo) 1995; 117: 14–18
   PubMed Web of Science ®Google Scholar
• Choi-Miura N.H., Sano Y., Oda E., Nakano Y., Tobe T., Yanagishita T., Taniyama M., Katagiri T., Tomita M. Purification and characterization of a novel glycoprotein which has significant homology to heavy chains of inter-alpha-trypsin inhibitor family from human plasma. J. Biochem. (Tokyo) 1995; 117: 400–407
   PubMed Web of Science ®Google Scholar
• Pu X.P., Iwamoto A., Nishimura H., Nagasawa S. Purification and characterization of a novel substrate for plasma kallikrein (PK-120) in human plasma. Biochim. Biophys. Acta 1994; 1208: 338–343
   PubMed Web of Science ®Google Scholar
• Himmelfarb M., Klopocki E., Grube S., Staub E., Klaman I., Hinzmann B., Kristiansen G., Rosenthal A., Durst M., Dahl E. ITIH5, a novel member of the inter-alpha-trypsin inhibitor heavy chain family is downregulated in breast cancer. Cancer Lett. 2004; 204: 69–77
   PubMed Web of Science ®Google Scholar
• Clark H.F., Gurney A.L., Abaya E., Baker K., Baldwin D., Brush J., Chen J., et al. The secreted protein discovery initiative (SPDI), a large-scale effort to identify novel human secreted and transmembrane proteins: a bioinformatics assessment. Genome Res. 2003; 13: 2265–2270
   PubMed Web of Science ®Google Scholar
• Whittaker C.A., Hynes R.O. Distribution and evolution of von Willebrand/integrin A domains: widely dispersed domains with roles in cell adhesion and elsewhere. Mol. Biol. Cell 2002; 13: 3369–3387
   PubMed Web of Science ®Google Scholar
• Suprenant K.A. Vault ribonucleoprotein particles: sarcophagi, gondolas, or safety deposit boxes?. Biochemistry 2002; 41: 14447–14454
   PubMed Web of Science ®Google Scholar
• Liu Y., Snow B.E., Kickhoefer V.A., Erdmann N., Zhou W., Wakeham A., Gomez M., et al. Vault poly(ADP-ribose) polymerase is associated with mammalian telomerase and is dispensable for telomerase function and vault structure in vivo. Mol. Cell Biol. 2004; 24: 5314–5323
   PubMed Web of Science ®Google Scholar
• Leveillard T., Salier J.P., Sesboue R., Bourguignon J., Diarra-Mehrpour M., Martin J.P. Dra I polymorphism in the human inter-alpha-trypsin inhibitor heavy chain gene ITIH1. Nucleic Acids Res. 1989; 17: 5419
   PubMed Web of Science ®Google Scholar
• Leveillard T., Salier J.P., Sesboue R., Bourguignon J., Diarra-Mehrpour M., Martin J.P. Sst I RFLP in the human inter-alpha-trypsin inhibitor heavy chain gene ITIH1. Nucleic Acids Res. 1988; 16: 11852
   PubMed Web of Science ®Google Scholar
• Leveillard T., Sesboue R., Salier J.P., Bourguignon J., Le Gueult L.C., Diarra-Mehrpour M., Martin J.P. An Apa I polymorphism for the human inter-alpha-trypsin inhibitor heavy chain gene ITIH1 on chromosome 3. Nucleic Acids Res. 1989; 17: 2875
   PubMed Web of Science ®Google Scholar
• Thiberville L., Bourguignon J., Beldjord C., Diarra-Mehrpour M., Nouvet G., Martin J.P. Detection by the polymerase chain reaction of two polymorphisms in exon 14 of the human inter-alpha-trypsin inhibitor heavy chain H1 gene. Hum. Genet. 1994; 93: 91–92
   PubMed Web of Science ®Google Scholar
• Leveillard T., Diarra-Mehrpour M., Salier J.P., Sesboue R., Bourguignon J., Martin J.P. Bgl I reveals two polymorphic sites in the human inter-alpha-trypsin inhibitor heavy chain gene ITI H2. Nucleic Acids Res. 1990; 18: 386
   PubMed Web of Science ®Google Scholar
• Leveillard T., Sirugo G., Hanauer A., Sesboue R., Bourguignon J., Diarra-Mehrpour M., Salier J.P., Martin J.P. An hypervariable polymorphism detected in the human inter-alpha-trypsin inhibitor heavy chain gene ITIH2. Nucleic Acids Res. 1990; 18: 1319
   PubMed Web of Science ®Google Scholar
• Leveillard T., Bourguignon J., Salier J.P., Diarra-Mehrpour M., Sesboue R., Martin J.P. Two RFLPs in human inter-alpha-trypsin inhibitor heavy chain gene ITIH2 on chromosome 10. Nucleic Acids Res. 1989; 17: 5418
   PubMed Web of Science ®Google Scholar
• Vogt U., Gurtler L., Cleve H. Inter-alpha-trypsin inhibitor polymorphism in African blacks. Electrophoresis 1992; 13: 337–338
   PubMed Web of Science ®Google Scholar
• Caeiro J.L., Liste I., Vogt U., Ribeiro J.C. Analysis of the inter-alpha-trypsin inhibitor polymorphism in west Africa: description of a new allele, ITI*7. Electrophoresis 1994; 15: 1191–1192
   PubMed Web of Science ®Google Scholar
• Harada A., Umetsu K., Suzuki T. Genetic polymorphism of the H1 subunit of inter-alpha-trypsin inhibitor. Int. J. Legal Med. 1995; 108: 113–115
   PubMed Web of Science ®Google Scholar
• Vogt U., Sesboue R., Bourguignon J., Diarra-Mehrpour M., Martin J.P., Cleve H. The polymorphism of the plasma inter-alpha-trypsin inhibitor (ITI) and its relationship to the heavy chain H1 subunit gene (ITIH1) at 3p211–212. Hum. Genet. 1994; 94: 39–44
   PubMed Web of Science ®Google Scholar
• Ding M., Umetsu K., Yuasa I., Sato M., Harada A., Suzuki T. Molecular basis of inter-alpha-trypsin inhibitor heavy chain H1 (ITIH1) polymorphism. Hum. Genet. 1995; 95: 435–436
   PubMed Web of Science ®Google Scholar
• Fujita Y., Ezura Y., Emi M., Sato K., Takada D., Iino Y., Katayama Y., et al. Hypercholesterolemia associated with splice-junction variation of inter-alpha-trypsin inhibitor heavy chain 4 (ITIH4) gene. J. Hum. Genet. 2004; 49: 24–28
   PubMed Web of Science ®Google Scholar
• Hutadilok N., Ghosh P., Brooks P.M. Binding of haptoglobin, inter-alpha-trypsin inhibitor, and alpha 1 proteinase inhibitor to synovial fluid hyaluronate and the influence of these proteins on its degradation by oxygen derived free radicals. Ann. Rheum. Dis. 1988; 47: 377–385
   PubMed Web of Science ®Google Scholar
• Yingsung W., Zhuo L., Morgelin M., Yoneda M., Kida D., Watanabe H., Ishiguro N., et al. Molecular heterogeneity of the SHAP-hyaluronan complex. Isolation and characterization of the complex in synovial fluid from patients with rheumatoid arthritis. J. Biol. Chem. 2003; 278: 32710–32718
   PubMed Web of Science ®Google Scholar
• Yoneda M., Zhao M., Zhuo L., Watanabe H., Yamada Y., Huang L., Nagasawa S., . Roles of inter-alpha-trypsin inhibitor and hyaluronan-binding proteoglycans in hyaluronan-rich matrix formaiton. New frontiers in Medical Sciences: Redefining Hyaluronan, G. Abatangelo, P.H. Weigel, et al. Elsevier Science B.V., Amsterdam 2000; 21–31
   Google Scholar
• Scarchilli L., Camaioni A., Bottazzi B., Negri V., Doni A., Deban L., Bastone A., et al. PTX3 interacts with inter-alpha -trypsin inhibitor implications for hyaluronan organization and cumulus oophorus expansion. J. Biol. Chem. 2007; 282: 30161–30170
   PubMed Web of Science ®Google Scholar
• Salustri A., Garlanda C., Hirsch E., De Acetis M., Maccagno A., Bottazzi B., Doni A., et al. PTX3 plays a key role in the organization of the cumulus oophorus extracellular matrix and in in vivo fertilization. Development 2004; 131: 1577–1586
   PubMed Web of Science ®Google Scholar
• Zhuo L., Kimata K. Cumulus oophorus extracellular matrix: its construction and regulation. Cell Struct. Funct. 2001; 26: 189–196
   PubMed Web of Science ®Google Scholar
• Sanggaard K.W., Karring H., Valnickova Z., Thogersen I.B., Enghild J.J. The TSG-6 and I alpha I interaction promotes a transesterification cleaving the protein-glycosaminoglycan-protein (PGP) cross-link. J. Biol. Chem. 2005; 280: 11936–11942
   PubMed Web of Science ®Google Scholar
• Rugg M.S., Willis A.C., Mukhopadhyay D., Hascall V.C., Fries E., Fulop C., Milner C.M., Day A.J. Characterization of complexes formed between TSG-6 and inter-alpha-inhibitor that act as intermediates in the covalent transfer of heavy chains onto hyaluronan. J. Biol. Chem. 2005; 280: 25674–25686
   PubMed Web of Science ®Google Scholar
• Fulop C., Szanto S., Mukhopadhyay D., Bardos T., Kamath R.V., Rugg M.S., Day A.J., et al. Impaired cumulus mucification and female sterility in tumor necrosis factor-induced protein-6 deficient mice. Development 2003; 130: 2253–2261
   PubMed Web of Science ®Google Scholar
• Carrette O., Nemade R.V., Day A.J., Brickner A., Larsen W.J. TSG-6 is concentrated in the extracellular matrix of mouse cumulus oocyte complexes through hyaluronan and inter-alpha-inhibitor binding. Biol. Reprod. 2001; 65: 301–308
   PubMed Web of Science ®Google Scholar
• Mukhopadhyay D., Hascall V.C., Day A.J., Salustri A., Fulop C. Two distinct populations of tumor necrosis factor-stimulated gene-6 protein in the extracellular matrix of expanded mouse cumulus cell-oocyte complexes. Arch. Biochem. Biophys. 2001; 394: 173–181
   PubMed Web of Science ®Google Scholar
• Garantziotis S., Hollingsworth J.W., Ghanayem R.B., Timberlake S., Zhuo L., Kimata K., Schwartz D.A. Inter-{alpha}-trypsin inhibitor attenuates complement activation and complement-induced lung injury. J. Immunol. 2007; 179: 4187–4192
   PubMed Web of Science ®Google Scholar
• Hinshelwood J., Spencer D.I., Edwards Y.J., Perkins S.J. Identification of the C3b binding site in a recombinant vWF-A domain of complement factor B by surface-enhanced laser desorption-ionisation affinity mass spectrometry and homology modelling: implications for the activity of factor B. J. Mol. Biol. 1999; 294: 587–599
   PubMed Web of Science ®Google Scholar
• Hui K.M., Orriss G.L., Schirmer T., Magnadottir B., Schifferli J.A., Inal J.M. Expression of functional recombinant von Willebrand factor-A domain from human complement C2: a potential binding site for C4 and CRIT. Biochem. J. 2005; 389: 863–868
   PubMed Web of Science ®Google Scholar
• Choi-Miura N.H., Takahashi K., Yoda M., Saito K., Hori M., Ozaki H., Mazda T., Tomita M. The novel acute phase protein, IHRP, inhibits actin polymerization and phagocytosis of polymorphonuclear cells. Inflamm. Res. 2000; 49: 305–310
   PubMed Web of Science ®Google Scholar
• Pineiro M., Andres M., Iturralde M., Carmona S., Hirvonen J., Pyorala S., Heegaard P.M., et al. ITIH4 (inter-alpha-trypsin inhibitor heavy chain 4) is a new acute-phase protein isolated from cattle during experimental infection. Infect. Immun. 2004; 72: 3777–3782
   PubMed Web of Science ®Google Scholar
• Kroczynska B., King-Simmons L., Alloza L., Alava M.A., Elguindi E.C., Blond S.Y. BIP co-chaperone MTJ1/ERDJ1 interacts with inter-alpha-trypsin inhibitor heavy chain 4. Biochem. Biophys. Res. Commun. 2005; 338: 1467–1477
   PubMed Web of Science ®Google Scholar
• Daveau M., Rouet P., Scotte M., Faye L., Hiron M., Lebreton J.P., Salier J.P. Human inter-alpha-inhibitor family in inflammation: simultaneous synthesis of positive and negative acute-phase proteins. Biochem. J. 1993; 292(Pt 2)485–492
   PubMed Web of Science ®Google Scholar
• Pugia M.J., Sommer R., Corey P., Anderson L., Gleason S., Jortani S.A., Elin R.J., et al. The uristatin dipstick is useful in distinguishing upper respiratory from urinary tract infections. Clin. Chim. Acta 2004; 341: 73–81
   PubMed Web of Science ®Google Scholar
• Duan X., Yarmush D., Berthiaume F., Jayaraman A., Yarmush M.L. Immunodepletion of albumin for two-dimensional gel detection of new mouse acute-phase protein and other plasma proteins. Proteomics 2005; 5: 3991–4000
   PubMed Web of Science ®Google Scholar
• Koomen J.M., Shih L.N., Coombes K.R., Li D., Xiao L.C., Fidler I.J., Abbruzzese J.L., Kobayashi R. Plasma protein profiling for diagnosis of pancreatic cancer reveals the presence of host response proteins. Clin. Cancer Res. 2005; 11: 1110–1118
   PubMed Web of Science ®Google Scholar
• Fung E.T., Yip T.T., Lomas L., Wang Z., Yip C., Meng X.Y., Lin S., et al. Classification of cancer types by measuring variants of host response proteins using SELDI serum assays. Int. J. Cancer 2005; 115: 783–789
   PubMed Web of Science ®Google Scholar
• Cho W.C., Yip T.T., Ngan R.K., Podust V.N., Yip C., Yiu H.H., Yip V., et al. ProteinChip array profiling for identification of disease- and chemotherapy-associated biomarkers of nasopharyngeal carcinoma. Clin. Chem. 2007; 53: 241–250
   PubMed Web of Science ®Google Scholar
• Lim Y.P., Bendelja K., Opal S.M., Siryaporn E., Hixson D.C., Palardy J.E. Correlation between mortality and the levels of inter-alpha inhibitors in the plasma of patients with severe sepsis. J. Infect. Dis. 2003; 188: 919–926
   PubMed Web of Science ®Google Scholar
• Opal S.M., Lim Y.P., Siryaporn E., Moldawer L.L., Pribble J.P., Palardy J.E., Souza S. Longitudinal studies of inter-alpha inhibitor proteins in severely septic patients: a potential clinical marker and mediator of severe sepsis. Crit. Care Med. 2007; 35: 387–392
   PubMed Web of Science ®Google Scholar
• Wu R., Cui X., Lim Y.P., Bendelja K., Zhou M., Simms H.H., Wang P. Delayed administration of human inter-alpha inhibitor proteins reduces mortality in sepsis. Crit. Care Med. 2004; 32: 1747–1752
   PubMed Web of Science ®Google Scholar
• Yang S., Lim Y.P., Zhou M., Salvemini P., Schwinn H., Josic D., Koo D.J., Chaudry I.H., Wang P. Administration of human inter-alpha-inhibitors maintains hemodynamic stability and improves survival during sepsis. Crit. Care Med. 2002; 30: 617–622
   PubMed Web of Science ®Google Scholar
• Jourdain M., Carrette O., Tournoys A., Fourrier F., Mizon C., Mangalaboyi J., Goudemand J., Mizon J., Chopin C. Effects of inter-alpha-inhibitor in experimental endotoxic shock and disseminated intravascular coagulation. Am. J. Respir. Crit. Care Med. 1997; 156: 1825–1833
   PubMed Web of Science ®Google Scholar
• Werbowetski-Ogilvie T.E., Agar N.Y., Waldkircher de Oliveira R.M., Faury D., Antel J.P., Jabado N., Del Maestro R.F. Isolation of a natural inhibitor of human malignant glial cell invasion: inter alpha-trypsin inhibitor heavy chain 2. Cancer Res. 2006; 66: 1464–1472
   PubMed Web of Science ®Google Scholar
• Daveau M., Jean L., Soury E., Olivier E., Masson S., Lyoumi S., Chan P., et al. Hepatic and extra-hepatic transcription of inter-alpha-inhibitor family genes under normal or acute inflammatory conditions in rat. Arch. Biochem. Biophys. 1998; 350: 315–323
   PubMed Web of Science ®Google Scholar
• Paris S., Sesboue R., Delpech B., Chauzy C., Thiberville L., Martin J.P., Frebourg T., Diarra-Mehrpour M. Inhibition of tumor growth and metastatic spreading by overexpression of inter-alpha-trypsin inhibitor family chains. Int. J. Cancer 2002; 97: 615–620
   PubMed Web of Science ®Google Scholar
• Monaco C., Negrini M., Sozzi G., Veronese M.L., Vorechovsky I., Godwin A.K., Croce C.M. Molecular cloning and characterization of LOH11CR2A, a new gene within a refined minimal region of LOH at 11q23. Genomics 1997; 46: 217–222
   PubMed Web of Science ®Google Scholar
• Chang N.S., Carey G., Pratt N., Chu E., Ou M. p53 overexpression and downregulation of inter-alpha-inhibitor are associated with hyaluronidase enhancement of TNF cytotoxicity in L929 fibroblasts. Cancer Lett. 1998; 131: 45–54
   PubMed Web of Science ®Google Scholar
• Worcester E.M. Inhibitors of stone formation. Semin. Nephrol. 1996; 16: 474–486
   PubMed Web of Science ®Google Scholar
• Atmani F., Mizon J., Khan S.R. Identification of uronic-acid-rich protein as urinary bikunin, the light chain of inter-alpha-inhibitor. Eur. J. Biochem. 1996; 236: 984–990
   PubMedGoogle Scholar
• Marengo S.R., Resnick M.I., Yang L., Chung J.Y. Differential expression of urinary inter-alpha-trypsin inhibitor trimers and dimers in normal compared to active calcium oxalate stone forming men. J. Urol. 1998; 159: 1444–1450
   PubMed Web of Science ®Google Scholar
• Dawson C.J., Grover P.K., Kanellos J., Pham H., Kupczyk G., Oates A., Ryall R.L. Inter-alpha-inhibitor in calcium stones. Clin. Sci. (Lond) 1998; 95: 187–193
   PubMed Web of Science ®Google Scholar
• Dawson C.J., Grover P.K., Ryall R.L. Inter-alpha-inhibitor in urine and calcium oxalate urinary crystals. Br. J. Urol. 1998; 81: 20–26
   PubMedGoogle Scholar
• Hedgepeth R.C., Yang L., Resnick M.I., Marengo S.R. Expression of proteins that inhibit calcium oxalate crystallization in vitro in the urine of normal and stone-forming individuals. Am. J. Kidney Dis. 2001; 37: 104–112
   PubMed Web of Science ®Google Scholar
• Atmani F., Khan S.R. Role of inter-alpha-inhibitor and its related proteins in urolithiasis. Purification of an inter-alpha-inhibitor related protein from the bovine kidney. Urol. Res. 1999; 27: 57–61
   PubMed Web of Science ®Google Scholar
• Moriyama M.T., Glenton P.A., Khan S.R. Expression of inter-alpha inhibitor related proteins in kidneys and urine of hyperoxaluric rats. J. Urol. 2001; 165: 1687–1692
   PubMed Web of Science ®Google Scholar
• Janssen U., Thomas G., Glant T., Phillips A. Expression of inter-alpha-trypsin inhibitor and tumor necrosis factor-stimulated gene 6 in renal proximal tubular epithelial cells. Kidney Int. 2001; 60: 126–136
   PubMed Web of Science ®Google Scholar
• Mizushima S., Nii A., Kato K., Uemura A. Gene expression of the two heavy chains and one light chain forming the inter-alpha-trypsin-inhibitor in human tissues. Biol. Pharm. Bull. 1998; 21: 167–169
   PubMed Web of Science ®Google Scholar
• Ricchiuti V., Hartke D.M., Yang L.Z., Goldman H.B., Elder J.S., Resnick M.I., Marengo S.R. Levels of urinary inter-alpha-trypsin inhibitor trimer as a function of age and sex-hormone status in males and females not forming stones. BJU Int. 2002; 90: 513–517
   PubMed Web of Science ®Google Scholar
• Dean C., Kanellos J., Pham H., Gomes M., Oates A., Grover P., Ryall R. Effects of inter-alpha-inhibitor and several of its derivatives on calcium oxalate crystallization in vitro. Clin. Sci. (Lond) 2000; 98: 471–480
   PubMed Web of Science ®Google Scholar
• Soury E., Olivier E., Daveau M., Hiron M., Claeyssens S., Risler J.L., Salier J.P. The H4P heavy chain of inter-alpha-inhibitor family largely differs in the structure and synthesis of its prolin-rich region from rat to human. Biochem. Biophys. Res. Commun. 1998; 243: 522–530
   PubMed Web of Science ®Google Scholar
• Tamura K., Dudley J., Nei M., Kumar S. MEGA4: Molecular evolutionary genetics analysis (MEGA) software version 4.0. Mol. Biol. Evol. 2007; 24: 1596–1599
   PubMed Web of Science ®Google Scholar